Knowles Corporation (KN) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. Knowles Corporation is a leading manufacturer of specialty electronic components serving medtech, defense, industrial, and electrification markets. The company operates through two reportable segments: Precision Devices and MedTech & Specialty Audio. Following the December 2024 divestiture of its Consumer MEMS Microphones (CMM) segment to Syntiant Corp., the company has reclassified CMM results as discontinued operations.
Key Financial Metrics (Three Months Ended Sept 30, 2025)
| Metric | Q3 2025 | Q3 2024 |
|---|---|---|
| Revenues | $152.9 million | $142.5 million |
| Gross Profit | $69.9 million | $62.9 million |
| Gross Margin | 45.7% | 44.1% |
| Operating Earnings | $25.8 million | $18.7 million |
| Net Earnings (Continuing Ops) | $18.0 million | $9.2 million |
| Diluted EPS (Continuing Ops) | $0.21 | $0.10 |
| Cash and Equivalents | $92.5 million | $130.1 million (Dec 31, 2024) |
| Total Debt | $176.3 million | $202.5 million (Dec 31, 2024) |
Material Changes vs. Prior Period
- Revenue Growth: Q3 2025 revenue increased 7.3% year-over-year, driven by higher demand in defense, electrification, and medtech markets within the Precision Devices segment, and increased shipping volumes of metal cans to Syntiant in the MedTech segment.
- Profitability: Operating earnings rose 38% to $25.8 million, supported by improved gross margins (up 160 bps) due to higher volumes, cost reductions, and increased factory utilization.
- Discontinued Operations: The prior year (Q3 2024) included a significant loss of $8.7 million from discontinued operations due to goodwill impairment related to the CMM divestiture. Q3 2025 recorded a minimal loss of $0.6 million from discontinued operations.
- Debt Reduction: Total debt decreased by approximately $26 million compared to year-end 2024, primarily due to repayments on the revolving credit facility and the Seller Note.
- Share Repurchases: The company repurchased 938,112 shares in Q3 2025 for $20.0 million. For the nine months ended Sept 30, 2025, total repurchases were $55.0 million.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects 2025 capital expenditures to range between 4% and 6% of revenues.
- Outlook: The Precision Devices segment has seen increased bookings and backlog for capacitor products for four consecutive quarters as industrial inventory levels normalize.
- Tariff Risks: The company is monitoring new U.S. tariffs (10% baseline plus country-specific) announced in April 2025. While management does not anticipate a material impact currently, they are implementing pricing actions and cost controls to mitigate risks.
- Accounting Corrections: The company corrected errors in historical stock-based compensation and working capital adjustments related to the CMM disposal, resulting in a $1.1 million decrease to earnings before taxes for the nine months ended Sept 30, 2025.
- Impairment: A $3.6 million impairment charge was recorded in the first nine months of 2025 related to machinery and equipment sold to Syntiant.
Investor Verification Checklist
- Discontinued Operations Impact: Verify the comparability of year-over-year earnings, as Q3 2024 included a massive goodwill impairment charge ($13.1 million) in discontinued operations that is absent in 2025.
- Non-GAAP Reconciliations: Review the reconciliation of Non-GAAP Adjusted EBIT ($34.5 million in Q3 2025) to understand the impact of excluded items like stock-based compensation ($5.9 million) and restructuring charges.
- Syntiant Relationship: Monitor the $4.4 million in revenue recognized from Syntiant in Q3 2025 and the status of the $77.2 million investment in Syntiant preferred stock.
- Debt Covenants: Confirm continued compliance with the Interest Coverage Ratio (3.00:1) and Total Net Leverage Ratio (3.75:1) under the amended credit facility.
- Share Count: Note the reduction in weighted-average shares outstanding (87.3 million diluted in Q3 2025 vs. 89.7 million in Q3 2024) due to aggressive buybacks.